Atlas Trials

A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism

Clinical trial NCT04209179 · TERMINATED

Trial details

NCT number
NCT04209179
Sponsor
Chugai Pharmaceutical
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypoparathyroidism
Start date
2020-07-23
Primary completion
2020-12-28
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.